Clinical trials
Phase 3 Cholangiocarcinoma trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
37 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2004 | 1 |
| 2008 | 2 |
| 2009 | 1 |
| 2010 | 1 |
| 2011 | 1 |
| 2014 | 4 |
| 2015 | 3 |
| 2016 | 1 |
| 2017 | 3 |
| 2018 | 2 |
| 2019 | 6 |
| 2020 | 1 |
| 2021 | 1 |
| 2023 | 4 |
| 2024 | 1 |
| 2026 | 4 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Unknown status | 10 |
| Terminated | 8 |
| Completed | 7 |
| Recruiting | 4 |
| Active, not recruiting | 4 |
| Not yet recruiting | 3 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Merck Sharp & Dohme LLC | 2 |
| Shi Ming | 2 |
| TransThera Sciences (Nanjing), Inc. | 2 |
| Asan Medical Center | 1 |
| AstraZeneca | 1 |
| Changhai Hospital | 1 |
| Concordia Laboratories Inc. | 1 |
| Dan Zandberg | 1 |
| Fudan University | 1 |
| Helsinn Healthcare SA | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Cholangiocarcinoma | 37 |
| Gallbladder Neoplasms | 11 |
| Biliary Tract Neoplasms | 8 |
| Bile Duct Neoplasms | 5 |
| Neoplasms | 3 |
| Carcinoma, Hepatocellular | 2 |
| Klatskin Tumor | 2 |
| Adenocarcinoma | 1 |
| Anus Neoplasms | 1 |
| Carcinoma, Merkel Cell | 1 |
Trials
Showing 1 to 25 of 37. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.